Skip to main content
. 2016 Dec 20;10:85–94. doi: 10.2147/OTT.S113932

Table 2.

Association of AZGP1 expression with clinicopathologic features of patients with esophageal squamous cell carcinoma (n=215)

Clinicopathologic features n AZGP1 expression, n (%)
χ2 P-value
Downregulation Normal expression
Age (years) 3.367 0.067
 ≤60 125 62 (49.6) 63 (50.4)
 >60 90 56 (62.2) 34 (37.8)
Gender 0.482 0.487
 Male 123 65 (52.8) 58 (47.2)
 Female 92 53 (57.6) 39 (42.4)
Location 3.512 0.173
 Upper 43 28 (65.1) 15 (34.9)
 Middle 108 53 (49.1) 55 (50.9)
 Lower 64 37 (57.8) 27 (42.2)
Tumor cell differentiation 0.654 0.721
 Well 31 15 (48.4) 16 (51.6)
 Moderate 135 75 (55.6) 60 (44.4)
 Poor 49 28 (57.1) 21 (42.9)
T category 5.992 0.112
 T1 14 4 (28.6) 10 (71.4)
 T2 43 23 (53.5) 20 (46.5)
 T3 78 41 (52.6) 37 (47.4)
 T4 80 50 (62.5) 30 (37.5)
N category 4.442 0.035*
 N0 116 56 (48.3) 60 (51.7)
 N1 99 62 (62.6) 37 (37.4)
TNM stage 8.080 0.018*
 I 11 2 (18.2) 9 (81.8)
 II 119 63 (52.9) 56 (47.1)
 III 85 53 (62.4) 32 (37.6)
General classification 0.590 0.899
 Medullary type 117 67 (57.3) 50 (42.7)
 Ulcerative type 54 28 (51.9) 26 (48.1)
 Sclerotic type 21 11 (52.4) 10 (47.6)
 Mushroom type 23 12 (52.2) 11 (47.8)

Notes:

*

Statistically significant.